Jim Cramer Offers His Take On Corning, Calls This Healthcare Stock A 'Terrific Spec'

5/23/24 8:25:41 AM ET

Ordnance And Accessories

Industrials

Telecommunications Equipment

Industrials

Get the next $AXON alert in real time by email

On CNBC's “Mad Money Lightning Round,” Jim Cramer said Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is a “terrific spec” and he recommended buying the same.

On May 9, Recursion Pharmaceuticals reported better-than-expected first-quarter financial results.

Corning Incorporated (NYSE:GLW) has “not been able to generate the kind of return that I've wanted,” Cramer said. “I would not be a buyer all the way up here.”

See Also: Jim Cramer Says This Industrial Stock Is Doing ‘Very Well’; Here’s His Take On Palantir

On May 7, Mizuho analyst John Roberts initiated coverage on Corning with a Neutral rating and announced a price target of $36.

When asked about Intuitive Machines, Inc. (NASDAQ:LUNR), Cramer said, “I'm not there on that.”

On May 14, Intuitive Machines reported a first-quarter GAAP loss of $2.70 per share.

The “Mad Money” host said he would hold off Axon Enterprise, Inc. (NASDAQ:AXON) right now.

On May 6, Axon Enterprise posted better-than-expected results for its first quarter, reporting adjusted earnings of $1.15 per share beating market estimates of 94 cents per share.

“I like defense contractors,” Cramer said when asked about Kratos Defense & Security Solutions, Inc. (NASDAQ:KTOS). “I think you stay on it, maybe even buy more.”

On May 7, Kratos Defense & Security posted stronger-than-expected results for its first quarter.

Merit Medical Systems, Inc. (NASDAQ:MMSI) is “good,” Cramer said.

On April 30, Merit Medical Systems posted upbeat results for the first quarter.

Price Action:

Corning shares gained 0.3% to settle at $36.58 on Wednesday.
Axon shares fell 1.1% to close at $284.87 on Wednesday.
Recursion Pharmaceuticals shares slipped 1.6% to settle at $9.36.
Intuitive Machines shares fell 1.2% to settle at $5.06 on Wednesday.
Kratos Defense shares fell 1.3% to settle at $21.41.
Merit Medical shares fell 0.2% to close at $82.14 on Wednesday.

Read Next: Top 5 Industrials Stocks That May Explode This Quarter

Image: Shutterstock

Get the next $AXON alert in real time by email

Crush Q1 2026 with the Best AI Superconnector

Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

AI-Powered Inbox

Context-aware email replies

Strategic Decision Support

Get Started with Standout.work

Recent Analyst Ratings for
$AXON
$GLW
$KTOS
$LUNR

Company	Date	Price Target	Rating	Analyst
Kratos Defense & Security Solutions Inc. $KTOS	4/6/2026	$85.00	Hold → Buy	Jefferies
Corning Incorporated $GLW	3/31/2026	$125.00	Hold	Truist
Merit Medical Systems Inc. $MMSI	2/26/2026	$78.00	Overweight → Equal Weight	Wells Fargo
Kratos Defense & Security Solutions Inc. $KTOS	2/18/2026	$79.00	Neutral	UBS
Merit Medical Systems Inc. $MMSI	2/6/2026	$107.00	Buy	BTIG Research
Corning Incorporated $GLW	1/29/2026		Overweight → Equal Weight	Fox Advisors
Kratos Defense & Security Solutions Inc. $KTOS	1/22/2026	$99.00	Neutral	Piper Sandler
Intuitive Machines Inc. $LUNR	1/9/2026	$20.00	Buy → Hold	Stifel

More analyst ratings

$AXON
$GLW
$KTOS
$LUNR
Press Releases

Fastest customizable press release news feed in the world

Merit Medical Systems to Announce First Quarter 2026 Results on April 30, 2026

SOUTH JORDAN, Utah, April 02, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a global leader of healthcare technology, announced today that it will release its financial results for the quarter ended March 31, 2026, after the close of the stock market on Thursday, April 30, 2026. Merit plans to hold its investor conference call on the same day (Thursday, April 30, 2026) at 4:30 p.m. Eastern (3:30 p.m. Central, 2:30 p.m. Mountain, and 1:30 p.m. Pacific). To access the conference call, please pre-register using the following link. Registrants will receive confirmation with dial-in details. A live webcast and slide deck can be accessed using this link. A link to bo

4/2/26 6:00:00 PM ET

Medical/Dental Instruments

Health Care

The Only Mach 2+ Commercial Fleet in the World Is Now Testing Reusable Hypersonic Space Systems -- and the Pentagon Is Writing the Checks

Issued on behalf of Starfighters Space, Inc.CAPE CANAVERAL, Fla., April 2, 2026 /CNW/ -- USA News Group News Commentary — The next arms race isn't being fought on the ground. It's being fought at 45,000 feet and Mach 2, in the stratosphere where hypersonic weapons are validated, reusable space systems are tested, and the gap between the United States and its adversaries is either closed or conceded. The Pentagon knows it. Congress knows it. And the capital flowing into the commercial aerospace sector right now reflects exactly that urgency. The U.S. Space Force is operating on a

4/2/26 2:02:00 PM ET

Telecommunications Equipment

Consumer Discretionary

Air Freight/Delivery Services

Industrial Machinery/Components

Merit Medical Acquires View Point Medical, Inc., expanding the Merit Therapeutic Oncology Portfolio

SOUTH JORDAN, Utah, April 01, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a global leader of healthcare technology, today announced it has acquired View Point Medical, Inc. (View Point). Through a merger transaction, View Point is now a wholly-owned subsidiary of Merit. View Point, located in Carlsbad, California, manufactures the OneMark® Detection Imaging System and OneMark Tissue Markers. The aggregate transaction consideration, including the assumption of ViewPoint liabilities, is approximately $140 million. Of that amount, $90 million was paid in cash at closing and two deferred payments of $25 million each are scheduled to be paid not later than the first and

4/1/26 9:15:00 AM ET

Medical/Dental Instruments

Health Care

$AXON
$GLW
$KTOS
$LUNR
Leadership Updates

Live Leadership Updates

Companies Unveiling Autonomous Defense System Amid Surge Toward $43 Billion Global Market

Integrated AI system empowers forces to detect, decide, and deploy faster than traditional command structuresNEW YORK, March 30, 2026 /CNW/ -- Market News Updates News Commentary - Autonomous systems are transforming defense operations by enabling militaries to conduct missions with reduced human intervention, increased precision, and faster decision-making cycles. These systems include unmanned aerial vehicles (UAVs), ground robots, maritime platforms, and AI-enabled command systems that support intelligence, surveillance, reconnaissance (ISR), and combat roles. Their integration is largely driven by advancements in artificial intelligence, sensor fusion, and real-time data processing, allo

3/30/26 8:45:00 AM ET

Consumer Electronics/Appliances

Technology

Military/Government/Technical

Industrials

Kratos Announces Appointment of David King to Board of Directors

SAN DIEGO, March 25, 2026 (GLOBE NEWSWIRE) -- Kratos Defense & Security Solutions, Inc. (NASDAQ:KTOS), a Technology, Hardware, Products, System and Software Company addressing the Defense, National Security and Commercial Markets, today announced that the Company has appointed David King to the Kratos Board of Directors, effective March 23, 2026. Mr. King will serve as a member of the Audit Committee of the Kratos Board of Directors. Mr. King has served as a senior executive and board member in the aerospace, defense, national security and government sectors for more than four decades. Mr. King previously served as an executive officer and a member of the board of directors of Dynetics, I

3/25/26 4:00:00 PM ET

Military/Government/Technical

Industrials

Recursion Announces Vicki Goodman, M.D., as Incoming Chief Medical Officer

Salt Lake City, UT, March 25, 2026 (GLOBE NEWSWIRE) -- Recursion (NASDAQ:RXRX), a leading clinical-stage TechBio company decoding biology to radically improve lives, today announced that Vicki Goodman, M.D., will become Recursion's Chief Medical Officer effective April 6, 2026 as David Mauro, M.D., Ph.D. transitions out of the role. As Recursion advances its pipeline and prepares for key clinical and regulatory milestones, which are consistent with previously communicated expectations, Dr. Goodman brings a rare and differentiated perspective of how to translate scientific promise into successful clinical programs. Her experience spans executive roles in biotech and large pharma, with p

3/25/26 7:59:00 AM ET

Biotechnology: Biological Products (No Diagnostic Substances)

Health Care

$AXON
$GLW
$KTOS
$LUNR
Financials

Live finance-specific insights

Merit Medical Systems to Announce First Quarter 2026 Results on April 30, 2026

SOUTH JORDAN, Utah, April 02, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a global leader of healthcare technology, announced today that it will release its financial results for the quarter ended March 31, 2026, after the close of the stock market on Thursday, April 30, 2026. Merit plans to hold its investor conference call on the same day (Thursday, April 30, 2026) at 4:30 p.m. Eastern (3:30 p.m. Central, 2:30 p.m. Mountain, and 1:30 p.m. Pacific). To access the conference call, please pre-register using the following link. Registrants will receive confirmation with dial-in details. A live webcast and slide deck can be accessed using this link. A link to bo

4/2/26 6:00:00 PM ET

Medical/Dental Instruments

Health Care

The Only Mach 2+ Commercial Fleet in the World Is Now Testing Reusable Hypersonic Space Systems -- and the Pentagon Is Writing the Checks

Issued on behalf of Starfighters Space, Inc.CAPE CANAVERAL, Fla., April 2, 2026 /CNW/ -- USA News Group News Commentary — The next arms race isn't being fought on the ground. It's being fought at 45,000 feet and Mach 2, in the stratosphere where hypersonic weapons are validated, reusable space systems are tested, and the gap between the United States and its adversaries is either closed or conceded. The Pentagon knows it. Congress knows it. And the capital flowing into the commercial aerospace sector right now reflects exactly that urgency. The U.S. Space Force is operating on a

4/2/26 2:02:00 PM ET

Telecommunications Equipment

Consumer Discretionary

Air Freight/Delivery Services

Industrial Machinery/Components

Merit Medical Acquires View Point Medical, Inc., expanding the Merit Therapeutic Oncology Portfolio

SOUTH JORDAN, Utah, April 01, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a global leader of healthcare technology, today announced it has acquired View Point Medical, Inc. (View Point). Through a merger transaction, View Point is now a wholly-owned subsidiary of Merit. View Point, located in Carlsbad, California, manufactures the OneMark® Detection Imaging System and OneMark Tissue Markers. The aggregate transaction consideration, including the assumption of ViewPoint liabilities, is approximately $140 million. Of that amount, $90 million was paid in cash at closing and two deferred payments of $25 million each are scheduled to be paid not later than the first and

4/1/26 9:15:00 AM ET

Medical/Dental Instruments

Health Care